[1]
“A Randomized Controlled Trail on the Efficacy of Topical Olopatadine Hydrochloride 0.1% and Ketotifen Fumarate 0.025% for the Relief of Symptoms of Vernal Keratoconjunctivitis”, mfm, vol. 31, no. 8, Sep. 2020, Accessed: Jul. 10, 2026. [Online]. Available: https://medicalforummonthly.com/index.php/mfm/article/view/2404